A0A0S2Z3F9 (A0A0S2Z3F9_HUMAN) Homo sapiens (Human)
Cyclin-dependent kinase 7 UniProtKBInterProInteractive Modelling
346 aa; Sequence (Fasta) ;
5 identical sequences: Homo sapiens: P50613; Pan troglodytes: A0A2I3S9X0, A0A6D2WVT0; Pan paniscus: A0A2R8ZZV4; Gorilla gorilla gorilla: G3RC03
It is possible new templates exist for this target since these models were created.
Available Structures
38 Experimental Structures
| Description | PDB ID | Oligo-state | Range | Seq id (%) | Ligands | |
|---|---|---|---|---|---|---|
| Structure of the human CDK-activating kinase |
Heteromer P50613; P51946; P51948; | 100.0 | 1×MG; 1×AGS; | |||
| Cryo-EM structure of CAK-THZ1 |
Heteromer P50613; P51946; P51948; | 100.0 | 1×V0G; | |||
| Structure of the human Mediator-bound transcription pre-initiation complex |
Heteromer A0JLT2; O15514; O43513; O60244; O75448; O75586; P13984; P18074; P19387; P19388; P19447; P20226; P24928; P29083; P29084; P30876; P32780; P35269; P36954; P50613; P51946; P51948; P52434; P52435; P52655; P52657; P53803; P61218; P62487; P62875; Q00403; Q13503; Q13888; Q13889; Q15528; Q6P2C8; Q6ZYL4; Q71SY5; Q92759; Q96G25; Q96HR3; Q96RN5; Q9BTT4; Q9BUE0; Q9H204; Q9H944; Q9NPJ6; Q9NVC6; Q9NWA0; Q9NX70; Q9P086; Q9ULK4; Q9Y2X0; Q9Y3C7; | 100.0 | 2×MG; 16×ZN; 1×SF4; | |||
| TFIID-based holo PIC on SCP promoter |
Heteromer A0A481BYI6; A0A4X1TRS6; A0A4X1TVZ5; A0A4X1VEK9; A0A4X1VKG7; A0A4X1VTX4; F1RKE4; I3LCB2; I3LCH3; O00268; P13984; P18074; P19447; P20226; P21675; P24928; P29083; P29084; P32780; P35269; P49848; P50613; P51946; P51948; P52655; P52657; P60899; Q00403; Q12962; Q13888; Q13889; Q15542; Q15543; Q15544; Q15545; Q16514; Q16594; Q5VWG9; Q6P1X5; Q6ZYL4; Q7Z7C8; Q92759; | 100.0 | 17×ZN; 1×SF4; 1×MG; | |||
| Human Mediator with RNA Polymerase II Pre-initiation complex |
Heteromer A0A287ADR4; A0A4X1TRS6; A0A4X1VEK9; A0A4X1VYD0; A0A7M4DUC2; A0JLT2; F1RKE4; I3LCB2; I3LCH3; I3LGP4; I3LSI7; O43513; O60244; O75586; P13984; P18074; P19447; P20226; P29083; P29084; P32780; P35269; P50613; P51946; P51948; P52655; P52657; P60899; Q00403; Q13503; Q13888; Q13889; Q15528; Q6P2C8; Q6ZYL4; Q92759; Q96G25; Q96HR3; Q9BTT4; Q9BUE0; Q9H204; Q9H944; Q9NPJ6; Q9NVC6; Q9NWA0; Q9P086; Q9Y3C7; | 100.0 | 1×SF4; 18×ZN; 1×MG; | |||
| Structure of the human CAK in complex with THZ1 |
Heteromer P50613; P51946; P51948; | 100.0 | 1×V0G; | |||
| Cryo-EM structure of CDK7 subunit of CAK in complex with inhibitor LDC4297 |
Heteromer P50613; P51948; | 100.0 | 1×WD9; | |||
| Cryo-EM structure of the human CAK bound to ICEC0942 at 2.5 Angstroms resolution |
Heteromer P50613; P51946; P51948; | 100.0 | 1×I74; | |||
| Cryo-EM structure of the human CAK bound to ICEC0942 (PHENIX-OPLS3e) |
Heteromer P50613; P51946; P51948; | 100.0 | 1×I74; | |||
| Cryo-EM structure of CAK in complex with inhibitor ICEC0574 |
Heteromer P50613; P51946; P51948; | 100.0 | 1×X4F; | |||
| Cryo-EM structure of CAK in complex with inhibitor ICEC0880 (ring-up conformation) |
Heteromer P50613; P51946; P51948; | 100.0 | 1×X3Z; | |||
| Cryo-EM structure of CAK in complex with inhibitor CT7030 |
Heteromer P50613; P51946; P51948; | 100.0 | 1×ZQ6; | |||
| Cryo-EM structure of CAK in complex with inhibitor ICEC0880 (ring-down conformation) |
Heteromer P50613; P51946; P51948; | 100.0 | 1×X3Z; | |||
| Cryo-EM structure of CAK in complex with inhibitor ICEC0942 |
Heteromer P50613; P51946; P51948; | 100.0 | 1×I74; | |||
| Cryo-EM structure of CAK in complex with inhibitor BS-194 |
Heteromer P50613; P51946; P51948; | 100.0 | 1×NS9; | |||
| Cryo-EM structure of CAK in complex with nucleotide analogue ATPgS |
Heteromer P50613; P51946; P51948; | 100.0 | 1×AGS; 1×MG; | |||
| Cryo-EM structure of CAK in complex with inhibitor ICEC0768 |
Heteromer P50613; P51946; P51948; | 100.0 | 1×X2Z; | |||
| Cryo-EM structure of CAK in complex with inhibitor ICEC0829 |
Heteromer P50613; P51946; P51948; | 100.0 | 1×X50; 1×X58; | |||
| Cryo-EM structure of CAK in complex with inhibitor BS-181 |
Heteromer P50613; P51946; P51948; | 100.0 | 1×X2H; | |||
| Cryo-EM structure of CAK in complex with inhibitor dinaciclib |
Heteromer P50613; P51946; P51948; | 100.0 | 1×1QK; | |||
| Cryo-EM structure of CAK in complex with inhibitor ICEC0943 |
Heteromer P50613; P51946; P51948; | 100.0 | 1×I73; | |||
| Cryo-EM structure of CAK in complex with inhibitor ICEC0510-S |
Heteromer P50613; P51946; P51948; | 100.0 | 1×X4Q; | |||
| Cryo-EM structure of CAK in complex with inhibitor ICEC0510-R |
Heteromer P50613; P51946; P51948; | 100.0 | 1×X4L; | |||
| Cryo-EM structure of CAK in complex with inhibitor ICEC0914 |
Heteromer P50613; P51946; P51948; | 100.0 | 1×X1W; | |||
| Cryo-EM structure of CAK with averaged inhibitor density |
Heteromer P50613; P51946; P51948; | 100.0 | ||||
| Human holo-PIC in the closed state |
Heteromer O15514; P13984; P18074; P19387; P19388; P19447; P20226; P23193; P24928; P29083; P29084; P30876; P32780; P35269; P36954; P50613; P51946; P51948; P52434; P52435; P52655; P52657; P53803; P61218; P62487; P62875; Q00403; Q13888; Q13889; Q6ZYL4; Q92759; | 100 | 2×MG; 17×ZN; 1×SF4; | |||
| RNA polymerase II pre-initiation complex with the distal +1 nucleosome (PIC-Nuc18W) |
Heteromer A0A287ADR4; A0A4X1TRS6; A0A4X1VEK9; A0A4X1VKG7; A0A4X1VYD0; A0A7M4DUC2; F1RKE4; I3LCB2; I3LCH3; I3LGP4; I3LSI7; P02281; P06897; P13984; P18074; P19447; P20226; P29083; P29084; P32780; P35269; P50613; P51946; P51948; P52655; P52657; P60899; P62799; P84233; Q00403; Q13888; Q13889; Q6ZYL4; Q92759; | 100 | 1×SF4; 17×ZN; 1×MG; | |||
| RNA polymerase II pre-initiation complex with the proximal +1 nucleosome (PIC-Nuc10W) |
Heteromer A0A287ADR4; A0A4X1TRS6; A0A4X1VEK9; A0A4X1VKG7; A0A4X1VYD0; A0A7M4DUC2; F1RKE4; I3LCB2; I3LCH3; I3LGP4; I3LSI7; P02281; P06897; P13984; P18074; P19447; P20226; P29083; P29084; P32780; P35269; P50613; P51946; P51948; P52655; P52657; P60899; P62799; P84233; Q00403; Q13888; Q13889; Q6ZYL4; Q92759; | 100 | 1×SF4; 16×ZN; 1×MG; | |||
| p53-bound TFIID-based holo PIC on HDM2 promoter |
Heteromer A0A481BYI6; A0A4X1TRS6; A0A4X1TVZ5; A0A4X1VEK9; A0A4X1VKG7; A0A4X1VTX4; F1RKE4; I3LCB2; I3LCH3; O00268; P13984; P18074; P19447; P20226; P21675; P24928; P29083; P29084; P32780; P35269; P49848; P50613; P51946; P51948; P52655; P52657; P60899; Q00403; Q12962; Q13888; Q13889; Q15542; Q15543; Q15544; Q15545; Q16514; Q16594; Q5VWG9; Q6P1X5; Q6ZYL4; Q7Z7C8; Q92759; | 100 | 16×ZN; 1×SF4; 1×MG; | |||
| Crystal structure of the dual T-loop phosphorylated Cdk7/CycH/Mat1 complex |
Heteromer P50613; P51946; P51948; | 100 | 3×EDO; | |||
| A soakable crystal form of human CDK7 in complex with AMP-PNP | monomer | 99.34 | 1×ANP; 1×MG; | |||
| A soakable crystal form of human CDK7 in complex with AMP-PNP | monomer | 99.65 | 2×PE3; 1×PEG; 1×YPK; | |||
| A soakable crystal form of human CDK7 in complex with AMP-PNP | monomer | 99.64 | 1×YN3; | |||
| A soakable crystal form of human CDK7 in complex with AMP-PNP | monomer | 98.95 | 1×PEG; 1×I74; | |||
| A soakable crystal form of human CDK7 in complex with AMP-PNP | monomer | 98.94 | 1×ANP; 1×MG; | |||
| A soakable crystal form of human CDK7 in complex with AMP-PNP | monomer | 99.29 | 1×YNK; | |||
| Crystal structure of the human CDK7 kinase domain in complex with LDC4297 | monomer | 100.0 | 1×WZ8; 2×GOL; 1×PGE; | |||
| Crystal Structure of Human CDK7 | monomer | 100.0 | 1×ATP; | |||
1 SWISS-MODEL model
| Template | Oligo-state | QMEAN | Range | Ligands | Trg-Tpl Seq id (%) | |
|---|---|---|---|---|---|---|
| 7lbm.1.8 | monomer | 0.82 | 100.00 | |||